Colgate Palmolive CO Form 4 insider transactions

Chief Financial Officer of Colgate-Palmolive, Stanley Sutula III, reports acquisition of restricted stock units and stock options, as well as disposition of shares for tax liability.

Prabha Parameswaran, Group President of Growth & Strategy at Colgate-Palmolive, reports acquisition and disposal of company stock and stock options.

EVP and Controller Gregory Malcolm reports acquisition of restricted stock units and stock options, along with tax-related share withholding.

John W. Kooyman, Chief of Staff at Colgate-Palmolive, reports acquisition of restricted stock units and stock options, as well as disposition of shares for tax obligations.

Jennifer Daniels, CLO and Secretary of Colgate-Palmolive, reports acquisition of restricted stock units and stock options, as well as a disposition of shares to cover tax liabilities.

Chief Human Resources Officer Sally Massey reported the acquisition and disposal of Colgate-Palmolive stock and stock options.

Gregory Malcolm, EVP and Controller at Colgate-Palmolive, reports a transaction involving common stock due to tax liability from vesting restricted stock units.

Director Hundmejean Martina reports exercising stock options and selling shares of Colgate-Palmolive common stock on August 23, 2024.

Panagiotis Tsourapas, Group President, Europe & Developing Markets at Colgate-Palmolive, exercised stock options and sold shares on August 8, 2024.

Jennifer Daniels, CLO and Secretary of Colgate-Palmolive, exercised stock options and sold shares to cover the exercise price and related taxes.

Sally Massey, Chief Human Resources Officer at Colgate-Palmolive, exercised stock options and sold shares to cover the exercise price and related taxes.

John W. Kooyman, Chief of Staff at Colgate-Palmolive, exercised stock options and sold shares on August 6, 2024.

Gregory Malcolm, EVP and Controller of Colgate-Palmolive, exercised stock options and sold shares to cover the exercise price and related taxes.

Panagiotis Tsourapas, Group President, Eur& Developing Mkts at Colgate-Palmolive, exercised stock options and sold shares on July 31, 2024.

Director Lorrie M Norrington acquired 274 shares of Colgate-Palmolive common stock at $95.61 per share on July 1, 2024.

Director Brian Newman reports acquisition and disposal of Colgate-Palmolive stock, including shares acquired through a deferred compensation plan and shares held by a family trust.

Director Lisa Edwards acquired 98 shares of Colgate-Palmolive common stock at $95.61 per share on July 1, 2024.

Director John P. Bilbrey acquired 222 shares of Colgate-Palmolive common stock at $95.61 per share on July 1, 2024, through a deferred compensation plan.

Jennifer Daniels, CLO and Secretary of Colgate-Palmolive, exercised stock options and sold shares on May 14, 2024.

Director John P. Bilbrey reports acquisition of Colgate-Palmolive stock and options as part of an annual director grant.

Director Harris C Martin reports receiving stock and option grants from Colgate-Palmolive on May 13, 2024.

Director Martina Hundmejean acquired 1,905 shares of common stock and an option to purchase 2,201 shares of common stock from Colgate-Palmolive on May 13, 2024.

Director Kimberly A Nelson receives stock grant and option award from Colgate-Palmolive.

Director Lorrie M Norrington received an annual stock grant and stock option grant from Colgate-Palmolive on May 13, 2024.

Director Steven A. Cahillane reports receiving stock and option grants from Colgate-Palmolive on May 13, 2024.

Director John T. Cahill reports acquisition of common stock and stock options from Colgate-Palmolive under the company's incentive compensation plan.

Director Lisa Edwards received stock and option grants from Colgate-Palmolive on May 13, 2024, according to a Form 4 filing with the SEC.

Director Brian Newman reports annual stock and option grants from Colgate-Palmolive, along with a clarification regarding shares held in a family trust.

Sally Massey, Chief Human Resources Officer at Colgate-Palmolive, exercised stock options and sold shares to cover the exercise price and related taxes.

Panagiotis Tsourapas, a Group President at Colgate-Palmolive, exercised stock options and sold shares on May 9, 2024.